Azaya Therapeutics

Providing Solutions To Improve the delivery of drug compounds with Nanotechnology

Azaya Therapeutics Announces the Addition of Two New Board Members

April 2011

Dear Stockholders -We are very pleased to announce the addition of two new Board members to the Azaya Therapeutics Board of Directors. Both Dr. Joseph P. Miller and Dr. Gary West have extensive experience in treating cancer patients and their advice and council will be important to Azaya Therapeutics as we advance our two current products through clinical development.

Azaya Therapeutics Presents Phase I Data at ASCO and Completes Offering

Monday, June 6, 2011

Phase I study conducted at two premier cancer research facilities in Texas
$3.5 million convertible debt offering closed

SAN ANTONIO, Texas – Azaya Therapeutics, Inc. presented data from its ongoing Phase I study of ATI-1123 today at the annual meeting of the American Society of Clinical Oncology held in Chicago, IL.

Azaya Sells More Than $3 Million in Debt in Private Placement

Monday, June 6, 2011

Azaya Therapeutics Inc. has completed a new round of private investment by raising $3.5 million through the issuance of 5-percent convertible notes sold to investors.